Tag Archives: vaccine

NIHR funded project that involves Universities of East Anglia, Leicester and Liverpool to help reduce the number of cases of flu in care homes

(PRESS RELEASE) LIVERPOOL, 21-Sep-2021 — /EuropaWire/ — University of Liverpool, one of the six original ‘red brick’ civic universities, has announced that its researchers are part of a new project to increase the number of care home staff that take … Read the full press release

AstraZeneca, EU agree to end legal proceedings over the delivery of the COVID-19 vaccine Vaxzevria

(PRESS RELEASE) CAMBRIDGE, 3-Sep-2021 — /EuropaWire/ — AstraZeneca (LSE/STO/Nasdaq: AZN), a British–Swedish multinational pharmaceutical and biopharmaceutical company, has announced an agreement between the Company and the European Commission has been reached that puts an end of the legal proceedings over … Read the full press release

COVID-19 Vaccine AstraZeneca confirmed safe and effective at preventing COVID-19

Increased efficacy with longer inter-dose interval Protection of over 70% starting after a first dose First indication of reduction in disease transmission of up to 67% (PRESS RELEASE) CAMBRIDGE, 3-Feb-2021 — /EuropaWire/ — AstraZeneca (LSE/STO/Nasdaq: AZN), a British–Swedish multinational pharmaceutical … Read the full press release

Flu vaccination campaign by the CERN Medical Service will begin on 2 November until 4 December 2020

(PRESS RELEASE) GENEVA, 26-Oct-2020 — /EuropaWire/ — CERN Medical Service, CERN’s unit responsible for the Organization’s occupational health & safety, has announced the dates of its flu vaccination campaign for 2020. As part of the flu vaccination campaign organised by … Read the full press release

The COVID-19 vaccine based on Sanofi’s recombinant protein-based technology and GSK’s pandemic adjuvant system secures 300 million doses order from the European Commission (EC)

Agreement signed today supports scale-up of manufacturing capabilities in several European countries Vaccine candidate uses Sanofi’s recombinant protein-based technology combined with GSK’s pandemic adjuvant system (PRESS RELEASE) PARIS, 18-Sep-2020 — /EuropaWire/ — Sanofi (EPA: SAN), a global biopharmaceutical company focused … Read the full press release

New EU / AstraZeneca deal to help EU member states access the AZD1222 COVID-19 vaccine at no profit during the pandemic

(PRESS RELEASE) CAMBRIDGE, 14-Aug-2020 — /EuropaWire/ — Global science-led biopharmaceutical company AstraZeneca (LSE/STO/NYSE: AZN) has announced it signed an agreement with the European Commission (EC) for the supply of up to 400 million doses of the AZD1222 COVID-19 vaccine. Building … Read the full press release

AstraZeneca expects to begin first deliveries of the University of Oxford’s vaccine in September 2020

The company received support of more than $1bn from the US Biomedical Advanced Research and Development Authority (BARDA) Broad and equitable supply of the vaccine throughout the world at no profit during the pandemic First agreements for at least 400 … Read the full press release

Atos provides solutions and computing power to help with the global fight against Covid-19

(PRESS RELEASE) PARIS, 28-Apr-2020 — /EuropaWire/ — Digital transformation leader, Atos brings its technology leadership, skills and innovation resources to the global fight against Covid-19. Atos is involved on multiple fronts to help contain the spread of the virus, providing … Read the full press release

Wellcome supports rapid response to the new Ebola outbreak in Congo with initial fund of up to £2 million

LONDON, 14-May-2018 — /EuropaWire/ — Wellcome is making an initial fund of up to £2 million available to support a rapid response to the new Ebola outbreak in the Democratic Republic of Congo (DRC). The pledge comes after the DRC … Read the full press release

University of York: Breakthrough in the search for an effective vaccine for the neglected tropical disease leishmaniasis

Scientists say they have made a major breakthrough in the search for an effective vaccine for the neglected tropical disease leishmaniasis following the successful completion of a first in-human trial. YORK, 07-Jun-2017 — /EuropaWire/ — The team, led by researchers … Read the full press release

University of East Anglia and the University of Leeds: Informing parents about the measles mumps and rubella (MMR) vaccine is the most cost-effective way of increasing its uptake

Norwich, UK, 28-7-2014 — /EuropaWire/ — Giving parents access to online information about the MMR vaccine is the most cost-effective way of increasing its uptake according to research from the University of East Anglia and the University of Leeds. A new report … Read the full press release